Here is a list of recent press releases. Please email for further information.
First genetic link for pilocytic astrocytoma identified
Researchers from the University of Cambridge have pinpointed a rearrangement of DNA that causes around two-thirds of all cases of pilocytic astrocytoma - the most common brain tumour in five to 19 year-olds - in a study funded by Samantha Dickson Brain Tumour Trust and Cancer Research UK.
Jonny Wilkinson kicks off major new study at Newcastle University
Rugby International and Newcastle Falcons star, Jonny Wilkinson, has launched a major new study into childhood brain tumours at an event in Newcastle. The study will trial a new UK-wide system for testing tumour samples and investigating a range of biological characteristics on a routine basis.
More information on the event, the research and media coverage
Brain tumour breakthough now benefiting patients- 3rd October 2008
The National Hospital of Neurology and Neurosurgery (NHNN), London, is implementing a molecular brain tumour test to improve diagnosis and treatment for malignant astorocytomas thanks to funding from the Samantha Dickson Brain Tumour Trust. For more information use the links below.
UK brain tumour researchers gave more presentations on their work than any other country except the USA at a recent major international conference in Chicago. Much of the research was funded by the Yateley-based Samantha Dickson Brain Tumour Trust. For more information use the links below.
For more information use the links below
Inequality in Research Funding
We are campaigning to increase funding for brain tumour research. The BBC South Today programme has hightlighted the inequalities in research spending which is currently far less than for many other cancers.
Other coverage includes:
BBC London featuring a little girl called Gemma
BBC East Midlands featuring Julian (starts at 15 mins)
Southampton Research Breakthrough
Brain Tumour Awareness Month 2008 Here are Statistics showing mortality and a graph showing mortality for 20 cancer types in 2005.
In association with a consortium of interested groups, SDBTT was to have appealed against NICE guidance in relation to the use of Temozolomide and Carmustine implants for the treatment of brain tumours earlier this year. The appeal was cancelled when NICE realised they had recognised a miscalculation in their appraisal model.
After keeping patients waiting for several months, NICE have now confirmed that it miscalculated the cost-effectiveness of Temozolomide earlier in the year.
 |
| Fiona Fullerton with some of the ICAP team in fancy dress - James Bond was the theme for this team.....how very appropriate! |
Neil and Angela Dickson joined patrons Sandy Lyle and Fiona Fullerton at ICAP in London to help raise funds for the Trust. ICAP set aside a charity day each year and this year over £7 million was raised around the world for good causes. The Charity will receive £190,000 towards brain tumour research.
This is a wonderful outcome and our thanks go to the whole London ICAP team.
